{"id":"W2987590359","doi":"10.1016/j.chest.2019.10.043","title":"Results of an Expert Consensus Survey on the Treatment of Pulmonary Arterial Hypertension With Oral Prostacyclin Pathway Agents","year":2019,"lang":"en","type":"review","venue":"CHEST Journal","topic":"Pulmonary Hypertension Research and Treatments","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"ca_institutions":"Jewish General Hospital; McGill University","funders":"Actelion Pharmaceuticals; School of Dental Medicine, University of Pittsburgh; St. Jude Medical; Cardiovascular Medical Research and Education Fund; Bayer Fund; Acceleron; University of Michigan; United Therapeutics Corporation; Meso Scale Diagnostics; GlaxoSmithKline; Novartis; Pfizer; Boehringer Ingelheim; Edwards Lifesciences; Bristol-Myers Squibb; Gilead Sciences; National Institutes of Health; Medtronic","keywords":"Medicine; Treprostinil; Intensive care medicine; Ambrisentan; Prostacyclin; MEDLINE; Endothelin receptor antagonist; Population; Clinical trial; Pulmonary hypertension; Internal medicine; Cardiology; Bosentan; Endothelin receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.2255933,0.0008268795,0.002585874,0.01339557,0.002234435,0.003714934,0.001970504,0.003131544,0.002681613],"category_scores_gemma":[0.3947677,0.0009058901,0.003910492,0.01099484,0.001619673,0.004037144,0.005819193,0.002237933,0.0004816931],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.006746792,"about_ca_system_score_gemma":0.01955547,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006134986,"about_ca_topic_score_gemma":0.007125455,"domain_scores_codex":[0.7165743,0.1649272,0.071461,0.008599329,0.03404993,0.004388264],"domain_scores_gemma":[0.4533185,0.3672537,0.04080324,0.006340595,0.1273551,0.004928858],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002396075,0.0007682874,0.180621,0.09360036,0.005820331,0.001037824,0.0983253,0.003191102,0.00195788,0.004369393,0.04385675,0.5640557],"study_design_scores_gemma":[0.001379361,0.00282808,0.449457,0.1354667,0.007239727,0.001794454,0.1703799,0.004948687,0.002421913,0.006873245,0.2163942,0.0008166934],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"review","genre_scores_codex":[0.6994393,0.124,0.02448045,0.05669622,0.002191894,0.01645433,0.01688586,0.0002932548,0.05955878],"genre_scores_gemma":[0.9056491,0.04068648,0.02621587,0.01132629,0.0003191385,0.00864567,0.005886685,0.0001026904,0.001168161],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.2255933,"threshold_uncertainty_score":0.9549814,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2360503095212629,"score_gpt":0.3829880529331033,"score_spread":0.1469377434118404,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}